Reincke M Fleseriu M Cushing syndrome: a review JAMA 2023 330 170 81 https://doi.org/10.1001/jama.2023.11305
Raff H Carroll T Cushing’s syndrome: from physiological principles to diagnosis and clinical care J Physiol 2015 593 493 506 https://doi.org/10.1113/jphysiol.2014.282871
Constantinescu SM Driessens N Lefebvre A Furnica RM Corvilain B Maiter D Etomidate infusion at low doses is an effective and safe treatment for severe Cushing’s syndrome outside intensive care Eur J Endocrinol 2020 183 161 7 https://doi.org/10.1530/eje-20-0380
Krasowski MD Drees D Morris CS Maakestad J Blau JL Ekins S Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction BMC Clin Pathol 2014 14 33 https://doi.org/10.1186/1472-6890-14-33
Preda VA Sen J Karavitaki N Grossman AB Therapy in endocrine disease: etomidate in the management of hypercortisolaemia in Cushing’s syndrome: a review Eur J Endocrinol 2012 167 137 43 https://doi.org/10.1530/eje-12-0274e
Carroll TB Peppard WJ Herrmann DJ Javorsky BR Wang TS Patel H Continuous etomidate infusion for the management of severe Cushing syndrome: validation of a standard protocol J Endocr Soc 2019 3 1 12 https://doi.org/10.1210/js.2018-00269
Monaghan PJ Owen LJ Trainer PJ Brabant G Keevil BG Darby D Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11 β-hydroxylase inhibitor metyrapone Ann Clin Biochem 2011 48 441 6 https://doi.org/10.1258/acb.2011.011014
Owen LJ Halsall DJ Keevil BG Cortisol measurement in patients receiving metyrapone therapy Ann Clin Biochem 2010 47 573 5 https://doi.org/10.1258/acb.2010.010167
Brossaud J Barat P Gualde D Corcuff JB Cross reactions elicited by serum 17-OH progesterone and 11-desoxycortisol in cortisol assays Clin Chim Acta 2009 407 72 4 https://doi.org/10.1016/j.cca.2009.05.019
